vs

Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and Star Equity Holdings, Inc. (STRR). Click either name above to swap in a different company.

Star Equity Holdings, Inc. is the larger business by last-quarter revenue ($56.8M vs $40.7M, roughly 1.4× PETMED EXPRESS INC). Star Equity Holdings, Inc. runs the higher net margin — -3.0% vs -26.0%, a 22.9% gap on every dollar of revenue. On growth, Star Equity Holdings, Inc. posted the faster year-over-year revenue change (69.0% vs -23.3%). Star Equity Holdings, Inc. produced more free cash flow last quarter ($-9.0M vs $-9.2M). Over the past eight quarters, Star Equity Holdings, Inc.'s revenue compounded faster (29.5% CAGR vs -20.9%).

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

Artists Equity is an American production company founded by actors and filmmakers Ben Affleck and Matt Damon in November 2022.

PETS vs STRR — Head-to-Head

Bigger by revenue
STRR
STRR
1.4× larger
STRR
$56.8M
$40.7M
PETS
Growing faster (revenue YoY)
STRR
STRR
+92.3% gap
STRR
69.0%
-23.3%
PETS
Higher net margin
STRR
STRR
22.9% more per $
STRR
-3.0%
-26.0%
PETS
More free cash flow
STRR
STRR
$268.0K more FCF
STRR
$-9.0M
$-9.2M
PETS
Faster 2-yr revenue CAGR
STRR
STRR
Annualised
STRR
29.5%
-20.9%
PETS

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
PETS
PETS
STRR
STRR
Revenue
$40.7M
$56.8M
Net Profit
$-10.6M
$-1.7M
Gross Margin
23.3%
Operating Margin
-25.7%
-0.2%
Net Margin
-26.0%
-3.0%
Revenue YoY
-23.3%
69.0%
Net Profit YoY
-1392.6%
-192.1%
EPS (diluted)
$-0.50
$-0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PETS
PETS
STRR
STRR
Q4 25
$40.7M
$56.8M
Q3 25
$44.4M
$48.0M
Q2 25
$51.2M
$35.5M
Q1 25
$50.8M
$31.9M
Q4 24
$52.0M
$33.6M
Q3 24
$58.0M
$36.9M
Q2 24
$66.2M
$35.7M
Q1 24
$65.1M
$33.9M
Net Profit
PETS
PETS
STRR
STRR
Q4 25
$-10.6M
$-1.7M
Q3 25
$-8.5M
$-1.8M
Q2 25
$-34.2M
$-688.0K
Q1 25
$-11.6M
$-1.8M
Q4 24
$-707.0K
$-585.0K
Q3 24
$2.3M
$-846.0K
Q2 24
$3.8M
$-441.0K
Q1 24
$-5.0M
$-2.9M
Gross Margin
PETS
PETS
STRR
STRR
Q4 25
23.3%
Q3 25
28.0%
43.0%
Q2 25
28.1%
Q1 25
29.9%
Q4 24
31.0%
Q3 24
32.3%
50.5%
Q2 24
28.8%
Q1 24
29.3%
Operating Margin
PETS
PETS
STRR
STRR
Q4 25
-25.7%
-0.2%
Q3 25
-18.9%
-3.4%
Q2 25
-66.7%
-0.6%
Q1 25
-11.9%
-5.4%
Q4 24
-0.9%
-0.4%
Q3 24
1.0%
-1.2%
Q2 24
6.6%
-0.5%
Q1 24
-5.9%
-9.0%
Net Margin
PETS
PETS
STRR
STRR
Q4 25
-26.0%
-3.0%
Q3 25
-19.2%
-3.7%
Q2 25
-66.7%
-1.9%
Q1 25
-22.9%
-5.5%
Q4 24
-1.4%
-1.7%
Q3 24
4.0%
-2.3%
Q2 24
5.7%
-1.2%
Q1 24
-7.7%
-8.6%
EPS (diluted)
PETS
PETS
STRR
STRR
Q4 25
$-0.50
$-0.49
Q3 25
$-0.41
$-0.54
Q2 25
$-1.65
$-0.23
Q1 25
$-0.56
$-0.59
Q4 24
$-0.03
$-0.21
Q3 24
$0.11
$-0.28
Q2 24
$0.18
$-0.15
Q1 24
$-0.24
$-0.95

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PETS
PETS
STRR
STRR
Cash + ST InvestmentsLiquidity on hand
$26.9M
$10.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$32.8M
$65.7M
Total Assets
$88.0M
$113.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PETS
PETS
STRR
STRR
Q4 25
$26.9M
$10.3M
Q3 25
$36.1M
$15.4M
Q2 25
$41.1M
$16.8M
Q1 25
$54.7M
$16.6M
Q4 24
$50.1M
$17.0M
Q3 24
$52.0M
$15.8M
Q2 24
$46.0M
$14.7M
Q1 24
$55.3M
$20.4M
Total Debt
PETS
PETS
STRR
STRR
Q4 25
Q3 25
$6.5M
Q2 25
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PETS
PETS
STRR
STRR
Q4 25
$32.8M
$65.7M
Q3 25
$43.1M
$67.8M
Q2 25
$51.5M
$40.1M
Q1 25
$85.1M
$39.5M
Q4 24
$96.2M
$40.4M
Q3 24
$96.4M
$42.9M
Q2 24
$93.5M
$42.6M
Q1 24
$96.7M
$44.3M
Total Assets
PETS
PETS
STRR
STRR
Q4 25
$88.0M
$113.2M
Q3 25
$100.3M
$117.1M
Q2 25
$109.8M
$55.6M
Q1 25
$148.7M
$53.2M
Q4 24
$144.8M
$52.6M
Q3 24
$146.0M
$52.6M
Q2 24
$152.7M
$52.6M
Q1 24
$169.9M
$52.6M
Debt / Equity
PETS
PETS
STRR
STRR
Q4 25
Q3 25
0.10×
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PETS
PETS
STRR
STRR
Operating Cash FlowLast quarter
$-9.2M
$-7.3M
Free Cash FlowOCF − Capex
$-9.2M
$-9.0M
FCF MarginFCF / Revenue
-22.7%
-15.8%
Capex IntensityCapex / Revenue
0.1%
3.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-23.0M
$-13.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PETS
PETS
STRR
STRR
Q4 25
$-9.2M
$-7.3M
Q3 25
$-2.2M
$-2.7M
Q2 25
$-12.3M
$139.0K
Q1 25
$7.0M
$-802.0K
Q4 24
$-1.2M
$-2.8M
Q3 24
$7.4M
$1.3M
Q2 24
$-8.5M
$-4.3M
Q1 24
$7.1M
$-1.8M
Free Cash Flow
PETS
PETS
STRR
STRR
Q4 25
$-9.2M
$-9.0M
Q3 25
$-4.8M
$-3.4M
Q2 25
$-13.6M
$102.0K
Q1 25
$4.6M
$-808.0K
Q4 24
$-1.9M
$-2.8M
Q3 24
$6.1M
$1.3M
Q2 24
$-9.2M
$-4.3M
Q1 24
$5.9M
$-1.8M
FCF Margin
PETS
PETS
STRR
STRR
Q4 25
-22.7%
-15.8%
Q3 25
-10.8%
-7.0%
Q2 25
-26.5%
0.3%
Q1 25
9.1%
-2.5%
Q4 24
-3.7%
-8.3%
Q3 24
10.6%
3.4%
Q2 24
-13.9%
-12.0%
Q1 24
9.0%
-5.3%
Capex Intensity
PETS
PETS
STRR
STRR
Q4 25
0.1%
3.0%
Q3 25
5.9%
1.3%
Q2 25
2.5%
0.1%
Q1 25
4.7%
0.0%
Q4 24
1.5%
0.1%
Q3 24
2.2%
0.0%
Q2 24
1.0%
0.0%
Q1 24
1.9%
0.0%
Cash Conversion
PETS
PETS
STRR
STRR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
3.18×
Q2 24
-2.27×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

STRR
STRR

Revenue From Other Contracts With Customers$27.6M49%
Other$24.3M43%
Energy Services Segment$4.9M9%

Related Comparisons